Management of localized and advanced prostate cancer in Canada: A lifetime cost and quality‐adjusted life‐year analysis

BACKGROUND To the authors' knowledge, the literature to date lacks studies examining lifetime costs and quality‐adjusted life‐years (QALYs) of prostate cancer (PCa) management strategies that integrate localized and advanced disease. The objective of the current study was to assess lifetime costs and QALYs associated with contemporary PCa management strategies across risk groups by integrating localized and advanced disease. METHODS The authors'...